DE60117583D1 - Liposomen welche antikanzeröse wirkstoffe verkapseln und deren verwendung zur behandlung von malignen tumoren - Google Patents

Liposomen welche antikanzeröse wirkstoffe verkapseln und deren verwendung zur behandlung von malignen tumoren

Info

Publication number
DE60117583D1
DE60117583D1 DE60117583T DE60117583T DE60117583D1 DE 60117583 D1 DE60117583 D1 DE 60117583D1 DE 60117583 T DE60117583 T DE 60117583T DE 60117583 T DE60117583 T DE 60117583T DE 60117583 D1 DE60117583 D1 DE 60117583D1
Authority
DE
Germany
Prior art keywords
treatment
anticanced
agents
liposomes
malignant tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60117583T
Other languages
English (en)
Other versions
DE60117583T2 (de
Inventor
Duena Antonio Parente
Lambiez Ferran Pons
Fres Angels Fabra
Trasancos Maria Dolores Polo
Garces Josep Garces
Isart Francesca Reig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GP Pharm SA
Original Assignee
Lipotec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec SA filed Critical Lipotec SA
Application granted granted Critical
Publication of DE60117583D1 publication Critical patent/DE60117583D1/de
Publication of DE60117583T2 publication Critical patent/DE60117583T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE60117583T 2000-10-10 2001-10-03 Liposomen welche antikanzeröse wirkstoffe verkapseln und deren verwendung zur behandlung von malignen tumoren Expired - Lifetime DE60117583T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200002447A ES2186484B1 (es) 2000-10-10 2000-10-10 Liposomas encapsulando farmacos anticancerosos y uso de los mismos en el tratamiento de tumores malignos.
ES200002447 2000-10-10
PCT/ES2001/000367 WO2002030397A1 (es) 2000-10-10 2001-10-03 Liposomas encapsulando farmacos anticancerosos y uso de los mismos en el tratamiento de tumores malignos

Publications (2)

Publication Number Publication Date
DE60117583D1 true DE60117583D1 (de) 2006-04-27
DE60117583T2 DE60117583T2 (de) 2006-10-05

Family

ID=8495226

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60117583T Expired - Lifetime DE60117583T2 (de) 2000-10-10 2001-10-03 Liposomen welche antikanzeröse wirkstoffe verkapseln und deren verwendung zur behandlung von malignen tumoren

Country Status (13)

Country Link
US (1) US7153490B2 (de)
EP (1) EP1325739B1 (de)
JP (1) JP4286535B2 (de)
AT (1) ATE318582T1 (de)
AU (1) AU9190401A (de)
BR (1) BR0113552A (de)
CA (1) CA2425271C (de)
DE (1) DE60117583T2 (de)
DK (1) DK1325739T3 (de)
ES (2) ES2186484B1 (de)
MX (1) MXPA03003125A (de)
PT (1) PT1325739E (de)
WO (1) WO2002030397A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968569B2 (en) * 2002-05-17 2011-06-28 Celgene Corporation Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
KR20050109958A (ko) * 2003-03-04 2005-11-22 가부시키가이샤 소세이 Ｇｍ-９５ 물질을 함유하는 항종양 효과 증강제, 항종양용조합 제제 및 항종양제
WO2005021012A1 (ja) * 2003-08-29 2005-03-10 Terumo Kabushiki Kaisha ゲムシタビン封入薬剤担体
CN1925871A (zh) * 2004-01-27 2007-03-07 南加州大学 聚合物结合的抗体癌症治疗剂
JP4972545B2 (ja) 2004-04-22 2012-07-11 セレーター ファーマスーティカルズ、インク． アントラサイクリン系薬剤及びシチジンアナログのリポソーム製剤
ES2293753B1 (es) * 2004-04-28 2009-03-16 Lipotec, S.A. Uso de peptidos xikvav en preparacion de composiciones cosmeticas para mejorar la firmeza de la piel mediante el aumento de la adhesion celular.
CN100438855C (zh) * 2006-01-19 2008-12-03 浙江大学 重酒石酸长春瑞滨脂质体及其冻干粉针与制备方法
CN101209243B (zh) * 2006-12-29 2010-12-08 石药集团中奇制药技术（石家庄）有限公司 一种脂质体药物及其制备方法
JP4966084B2 (ja) 2007-04-25 2012-07-04 エスアイアイ・プリンテック株式会社 インクジェットヘッドの駆動方法、インクジェットヘッドおよびインクジェット記録装置
US8067432B2 (en) * 2008-03-31 2011-11-29 University Of Kentucky Research Foundation Liposomal, ring-opened camptothecins with prolonged, site-specific delivery of active drug to solid tumors
WO2010135714A2 (en) 2009-05-22 2010-11-25 The Methodist Hospital Research Institute Methods for modulating adipocyte expression using microrna compositions
CN103083239B (zh) 2012-12-26 2015-11-25 中国人民解放军第四军医大学 一种蟾毒灵脂质体及其制备方法和应用
EP3265063A4 (de) 2015-03-03 2018-11-07 Cureport, Inc. Doppelt beladene liposomale pharmazeutische formulierungen
CN107530283A (zh) 2015-03-03 2018-01-02 奎尔波特股份有限公司 组合脂质体药物制剂
CN106955271A (zh) * 2016-01-08 2017-07-18 佛山英特医药科技有限公司 奥沙利铂聚集体及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153955A1 (de) 1983-09-06 1985-09-11 Health Research, Inc. Verfahren zum verabreichen von liposomen zum herabsetzen der toxizität eines antitumor-arzneimittels
EP0211042A1 (de) * 1985-01-18 1987-02-25 Cooper-Lipotech, Inc. Liposomenzusammensetzungen und verfahren
US4797285A (en) 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
EP0543871A1 (de) 1990-08-08 1993-06-02 Liposome Technology, Inc. Stabile doxorubicin/liposom zusammensetzung
ES2072223B1 (es) 1993-11-25 1996-03-16 Lipotec Sa Liposomas encapsulando doxorubicina.
US6071532A (en) * 1996-10-15 2000-06-06 Emory University Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof

Also Published As

Publication number Publication date
WO2002030397A9 (es) 2004-05-13
DE60117583T2 (de) 2006-10-05
US7153490B2 (en) 2006-12-26
EP1325739A1 (de) 2003-07-09
CA2425271C (en) 2011-04-19
DK1325739T3 (da) 2006-07-10
CA2425271A1 (en) 2003-04-08
AU9190401A (en) 2002-04-22
US20050100590A1 (en) 2005-05-12
MXPA03003125A (es) 2004-05-04
ES2186484A1 (es) 2003-05-01
ES2259674T3 (es) 2006-10-16
EP1325739B1 (de) 2006-03-01
JP2004510811A (ja) 2004-04-08
BR0113552A (pt) 2003-07-29
ES2186484B1 (es) 2004-07-01
AU2001291904B2 (en) 2006-05-11
ATE318582T1 (de) 2006-03-15
WO2002030397A1 (es) 2002-04-18
PT1325739E (pt) 2006-07-31
JP4286535B2 (ja) 2009-07-01

Similar Documents

Publication Publication Date Title
DE60117583D1 (de) Liposomen welche antikanzeröse wirkstoffe verkapseln und deren verwendung zur behandlung von malignen tumoren
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
ATE288743T1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
ATE216220T1 (de) Osmotische darreichungsform mit zwei mantelschichten
DE60321929D1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
ATE232100T1 (de) Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
NO20032027L (no) Effektive antitumorbehandlinger
BRPI0518250A2 (pt) tratamentos anticÂncer
DE69426334T2 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
DE69815094D1 (de) 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen
HK1068606A1 (en) Novel aminobenzoephenones
DE69822496D1 (de) Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen
ATE103804T1 (de) Pharmazeutische praeparate.
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
DE69700983D1 (de) Ligandgerichtete enzyme-prodrug therapie
DE50008032D1 (de) Pharmazeutische zusammensetzung aus spinnengiften sowie deren herstellung und verwendung zur behandlung von tumorerkrankungen
ATE414100T1 (de) Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
ATE411051T1 (de) Polypeptid, dessen konjugat doxorubicin enthält, und auf diesem basierende pharmazeutische zusammensetzung
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
EA200100311A1 (ru) Бифункциональные антитела и их применение для прицельной доставки противоопухолевых средств
GEP20002312B (en) Ointment for Treatment of Osteoarticular System with Herbs
DE60121449D1 (de) Behandlung von hepatitis c mit thymosin und pegyliertem interferon
RU98100028A (ru) Способ эндолимфатической терапии заболеваний и повреждений позвоночника и спинного мозга

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GP PHARM S.A., BARCELONA, ES